Unlocking the Future of Precision Medicine

Innovative Solutions for Oncology and Autoimmune Diseases

Discover how Snap Bio-Science is revolutionizing treatment with our cutting-edge SNAP-CAR technology.

About Snap Bio-Science

Snap Bio-Science is at the forefront of developing advanced therapeutic solutions for oncology and autoimmune diseases. Our proprietary SNAP-CAR platform leverages monoclonal antibodies conjugated to benzyl guanine linkers, recognized by custom SNAP-CAR cells. This allows for tunable and targeted treatments, offering hope for patients with hematological malignancies and solid tumors. Our mission is to harness the power of innovative science to create life-changing therapies.

Read Our Story

Advantages of SNAP-CAR Technology

Our SNAP-CAR platform offers unique benefits that set us apart in the field of precision medicine.

Multiple Targets and Indications

Utilize universal SNAP-CAR cells with multiple anti-tumor antibodies to target a wide range of hematological malignancies and solid tumors.

Tunable Activity

Avoid toxicity, such as cytokine release syndrome, by precisely titrating the antibody dose for optimal therapeutic effect.

Versatile Effector Cells

Generate a variety of SNAP-CAR effector cells, including T cells and NK cells, for use in both autologous and allogeneic settings.

Proven Safety and Efficacy

Our SNAP-CAR technology has demonstrated safety and efficacy in preclinical studies, positioning us for successful clinical outcomes.

Our Journey

From our inception to our current innovations, explore the milestones that have shaped Snap Bio-Science.

Learn More

'15

Company Founded

Snap Bio-Science was established with a mission to revolutionize CAR-based therapies.

'17

First Research Collaboration

We entered into a pivotal research agreement with the University of Pittsburgh to develop SNAP-CAR products.

'19

Preliminary Results

Presented promising preliminary results from studies conducted on NSG mice, showing significant tumor reduction.

'21

Expansion of Research

Expanded our research to include multiple targets and indications, enhancing our SNAP-CAR technology.

Our Impact

Key statistics highlighting our progress and achievements.

Success Rate in Preclinical Trials 95% 95%
Reduction in Tumor Size 85% 85%
Survival Rate in NSG Mice 75% 75%

Research Funding Increase 90% 90%
Positive Feedback from Partners 80% 80%
Market Share in CAR Therapies 70% 70%

Market Analysis

The Future of CAR-Based Therapies in Autoimmune Diseases

Join the Future of Biomedical Innovation

Discover how Snap Bio-Science is revolutionizing oncology and autoimmune treatments with our cutting-edge SNAP-CAR technology. Get involved or support our groundbreaking research to help us bring life-changing therapies to patients worldwide.